Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
04/2014
04/08/2014US8691238 High growth reassortant influenza A virus
04/08/2014US8691223 Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof
04/08/2014US8691215 Anti-viral protection with viruses containing defective genome segments
04/08/2014US8691209 Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
04/03/2014WO2014052789A1 Aav vectors targeted to oligodendrocytes
04/03/2014WO2014051111A1 Hepatitis c virus particles formation promoter, and method for producing hepatitis c virus particles
04/03/2014WO2014049094A1 Recombinant measles virus expressing chikungunya virus polypeptides and their applications
04/03/2014WO2014048955A1 Arterivirus
04/03/2014WO2014048500A1 Novel mva virus and uses thereof
04/03/2014US20140093536 Compositions And Methods For Treatment Of Microbial Infections
04/02/2014EP2712871A1 Recombinant Measles virus expressing Chikungunya virus polypeptides and their applications
04/02/2014EP2712624A1 Combination vaccine comprising an attenuated bovine viral diharrhea virus
04/02/2014CN103703133A Mutant replicon derived from genome of hepatitis c virus j6cf strain
04/02/2014CN103695470A Lentivirus recombinant expression vector/recombinant lentivirus, as well as application, host cell and preparing method thereof
04/02/2014CN103695465A CDNA (Complementary Deoxyribonucleic Acid) infectious clone of porcine reproductive and respiratory syndrome virus vaccine strain and application thereof
04/02/2014CN103695450A Construction method for competition experiment system of fluorescent recombinant viruses
04/02/2014CN103695426A Small interfering RNA (Ribonucleic Acid) and recombinant vector for knocking down Syntaxin7 and application of small interfering RNA and recombinant vector
04/02/2014CN103695377A Cultivating and preparing method of I-type dengue virus KMB17 cell adapted strain
04/02/2014CN103695366A Goldfish kidney cell line and application thereof
04/02/2014CN102994458B Porcine pseudorabies virus virulent strain, and gene deletion vaccine strain thereof and applications thereof
04/02/2014CN102964434B Recombinant encephalitis B virus and application thereof
04/02/2014CN102653772B Compositions of erythropoietin isoforms comprising lewis-x structures and high sialic acid content
04/02/2014CN102649812B Powdery mildew resistance-related protein TaWRKY1 and coding gene thereof
04/02/2014CN102649811B Protein TaWRKY2 related to powdery mildew resistance and coding gene of protein TaWRKY2
04/02/2014CN102505022B RNA interference vector capable of simultaneously silencing multiple ligands of NKG2D, and construction method and application thereof
04/02/2014CN102414313B Recombinant virus-like particles encoded by multi-gene vector
04/01/2014US8686126 HBV drug resistance methods
04/01/2014US8685893 Phage display
04/01/2014US8685734 Viral purification methods
04/01/2014US8685722 Bovine adeno-associated viral (BAAV) vector and uses thereof
04/01/2014US8685695 Method for producing a mixture of bacteriophages and the use thereof in the therapy of antibiotic-resistant staphylococci
04/01/2014US8685694 Methods and compositions comprising bacteriophage nanoparticles
04/01/2014US8685412 Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing development of calicivirus disease
04/01/2014US8685410 Influenza hemagglutinin and neuraminidase variants
04/01/2014US8685387 Simian E adenoviruses SAdV-39, -25.2, -26, -30, -37, and -38
03/2014
03/27/2014WO2014047261A1 Viruses associated with immunodeficiency and enteropathy and methods using same
03/27/2014WO2014046410A1 Method for producing virus-like particles of nodavirus, yeast cell line expressing same, and vaccine composition containing same
03/27/2014WO2014045254A2 Human betacoronavirus lineage c and identification of n-terminal dipeptidyl peptidase as its virus receptor
03/27/2014WO2014045055A1 Nanoparticle synthesis using plant extracts and virus
03/27/2014WO2014044067A1 In vitro preparation method of rotavirus double-layer virus-like particles
03/27/2014WO2013188673A3 Reassortant btv and ahsv vaccines
03/27/2014US20140087445 Method of making ligand functionalized substrates
03/26/2014EP2711427A1 HCV gene
03/26/2014EP2710116A2 Avirulent modified salmonella gallinarum strains and pharmaceutical composition using the same
03/26/2014EP2709639A1 Combination of oncolytic adenoviruses with histone deacetylase inhibitors
03/26/2014CN103687942A Virus-like particles and process for preparing same
03/26/2014CN103687615A Canine coronavirus vaccine
03/26/2014CN103667350A Vector system for transforming packaging cell tropism of retrovirus and methods thereof
03/26/2014CN103667319A Human papilloma virus (HPV) resistant trivalent vaccine as well as preparation method and application thereof
03/26/2014CN103667250A Wheat stripe rust resistance related protein and coding gene and application thereof
03/26/2014CN103667199A Method for preparing rotavirus bilayer virus-like particles in vitro
03/26/2014CN103667198A Construction and application of recombinant duck viral enteritis virus vaccine for expressing secretory duck Tembusu virus E protein
03/26/2014CN103667197A Construction and application of recombinant duck viral enteritis virus vaccine for expressing secretory duck Tembusu virus M/E protein
03/26/2014CN103667196A Vaccine composition containing porcine circovirus-2 antigen and swine flu antigen
03/26/2014CN103667176A Carassius auratus gibelio brain tissue cell line sensitive to cyprinid herpesvirus II, and establishing method and application thereof
03/26/2014CN103667060A Agar culture medium
03/26/2014CN103665150A Porcine beta2 epinephrine receptor fusion protein as well as encoding gene thereof and expression method
03/26/2014CN103656682A Anti-O-type foot-and-mouth disease polypeptide-nucleic acid double-effect virus-like particle vaccine and preparation method thereof
03/26/2014CN103656677A Medicine composition for treating neuron degeneration disease
03/26/2014CN102755644B Rabbit haemorrhagic disease tissue inactivated vaccine and preparation method thereof
03/26/2014CN102732487B Method for large scale cultivation in bioreactor
03/26/2014CN102676414B Genetic manipulation system based on Haloarcula hispanica and pyrF gene and its application
03/26/2014CN102633878B H1-subtype influenza A virus double-antibody sandwich ELISA kit and application
03/26/2014CN102533680B Virus-like particles for pseudorabies virus and preparation method for same
03/26/2014CN102533671B Coxsackie virus A16-type virus strain and applications thereof
03/26/2014CN102517317B Preparation method and application of enterovirus 71 type full-length infectious clone with tags
03/26/2014CN101516395B A vaccine for chikungunya virus infection
03/25/2014US8680244 Method for the production of antibodies that bind to multiple membrane spanning proteins
03/25/2014US8680068 Herpes virus strains
03/25/2014US8680018 Selection system
03/25/2014US8679837 Inducible system for highly efficient production of recombinant Adeno-associated virus (rAAV) vectors
03/25/2014US8679830 Viral vectors
03/25/2014US8679819 Mutant cells with altered sialic acid
03/25/2014US8679736 Removal of adenine during a pathogen reduction process in whole blood or red blood cells by dilution
03/25/2014CA2584815C Stable and filterable enveloped virus formulations
03/20/2014WO2014043189A1 Conditionally replication deficient herpes viruses and use thereof in vaccines
03/20/2014WO2014042209A1 Peptides that bind to epithelial cell adhesion molecule
03/20/2014US20140080114 Methods, kits and compositions for inactivation of viral agents in whole blood and red blood cell concentrates
03/20/2014US20140079671 Antibacterial Phage, Phage Peptides And Methods Of Use Thereof
03/19/2014EP2707480A1 Virus-like particles and process for preparing same
03/19/2014EP2707027A1 Papaya mosaic virus compositions and uses thereof for stimulation of the innate immune response
03/19/2014EP2706840A2 Wdr13 as a novel biomarker useful for treating diabetes and cancer
03/19/2014CN103648528A Papaya mosaic virus compositions and uses thereof for stimulation of the innate immune response
03/19/2014CN103642761A Respiratory syncytial virus-like particles and preparation method and application thereof
03/19/2014CN103642760A Method for preparing Coxsackie A16 virus complete solid particles
03/19/2014CN103642759A Recombined infectious bronchitis virus embedded with IBV 4/91 strain spike protein ectodomain gene fragment, construction method and application of virus
03/19/2014CN103642758A Recombinant baculovirus expressing novel duck reovirus outer capsid proteins and construction method thereof
03/19/2014CN102839159B CoxA16 virus strain and human CoxA16 inactivated vaccine
03/19/2014CN102295688B Plant fiber length related protein, and coding gene and application thereof
03/18/2014US8673613 Influenza B viruses having alterations in the hemaglutinin polypeptide
03/18/2014US8673612 Synthetic viruses and uses thereof
03/18/2014US8673319 Chimpanzee adenovirus vaccine carriers
03/18/2014US8673318 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
03/18/2014US8673316 Avirulent, immunogenic flavivirus chimeras
03/18/2014US8673291 Diffocin and methods of use thereof
03/13/2014WO2014040040A1 Attenuated parvovirus vaccine for muscovy duck parvovirus and goose parvovirus ( derzsy's disease)
03/13/2014WO2014037409A1 Vsv-hiv viral particles lacking reverse transcriptase functionality and therapeutic applications thereof
03/13/2014WO2014036807A1 Recombinant herpes simplex virus, preparation method therefor and application thereof
03/13/2014WO2014036735A1 Use of duck enteritis viral vaccine strain as expression vector for preparing recombinant viral vaccine for preventing galliformes avian diseases
03/13/2014WO2014036645A1 Picornavirus-like particle production in plants
1 ... 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 ... 267